Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Completed · Phase 1

Conditions studied: Brain Cancer, Arthritis, Rheumatoid, Central Nervous System Neoplasms, Glioma

In brief

The purpose of this study is to determine whether \[18F\]FHBG is suitable for use as an imaging probe in cancer or rheumatoid arthritis patients enrolled in cell or gene therapy trials. In this phase 1 study we will assess the safety and biodistribution of \[18F\]FHBG in patients.

Key facts

Study ID

NCT00185848

Run by

Sanjiv Sam Gambhir

People needed

10

Starts

2005-04-01

Expected to finish

2013-06-01

Last updated by the study team

2017-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of brain tumor or rheumatoid arthritis

You may not qualify if…

• Below 18 years of age

Where it is running

• University of California Los Angeles — Los Angeles, California, United States
• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.